RxDoctor Payments Data

Brian Wolf

Hematology & Oncology · Santa Monica, CANPI 1730640772

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,584 of the $2,225 with a category attached, or 71.2%. 21 manufacturers reported payments, led by AstraZeneca at 26.8% of the total. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.

$2,225in general payments, 2019–2025

Across 58 payments — averaging $38.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$596
  • Johnson & Johnson$301
  • AbbVie$209
  • Astellas Pharma US Inc$189
  • Genmab U.S., Inc.$127
  • Exelixis Inc.$125
  • plus $679 from 15 others

What the payments were for

  • Food & beverage$1,58471%
  • Education$64129%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,225 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Santa Monica

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →